SCHEMBL1766124

SCHEMBL1766124

O=C1CC(c2ccco2)CC(=O)C1C(=O)Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
ALOX15 P16050 3/20 0.51
HSD17B10 Q99714 3/20 0.51
MEN1 O00255 2/20 0.51
USP2 O75604 1/20 0.51
POLB P06746 7/20 0.49
TDP1 Q9NUW8 5/20 0.49
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
RECQL P46063 2/20 0.49
APOBEC3A P31941 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
ALDH1A1 P00352 5/20 0.46
ALOX12 P18054 2/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 1/20 0.46
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11122328 0.88 KMT2A (0.47) KMT2AALOX15HSD17B10MEN1USP2
SCHEMBL11166521 0.88 POLB (0.58) KMT2AALOX15HSD17B10MEN1USP2
SCHEMBL11126064 0.83 SMN1; SMN2 (0.49) KMT2AALOX15HSD17B10MEN1USP2
SCHEMBL11122610 0.83 POLB (0.49) KMT2AALOX15HSD17B10MEN1POLB
SCHEMBL14867379 0.80 SMN1; SMN2 (0.49) KMT2AMEN1POLBTDP1MAPT
SCHEMBL12648141 0.79 POLB (0.52) KMT2AALOX15HSD17B10MEN1USP2
SCHEMBL1782631 0.77 POLB (0.56) KMT2AALOX15HSD17B10MEN1USP2
SCHEMBL12648261 0.74 POLB (0.54) KMT2AALOX15HSD17B10MEN1POLB
SCHEMBL14867405 0.74 POLB (0.54) KMT2AALOX15HSD17B10MEN1USP2
SCHEMBL1766100 0.74 RXFP1 (0.46) KMT2AMEN1USP2POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US claimed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US claimed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
EP-2501229-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS University Of Rochester (US) 2012-09-26 EP disclosed
WO-2011062964-A1 COMPOUNDS AND METHODS FOR ALTERING LIFESPAN OF EUKARYOTIC ORGANISMS UNIVERSITY OF ROCHESTER (US) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms HDAC5, AADAC, SIRT1 KMT2A 2341/4885ALOX15 161/4885HSD17B10 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.